Is Pfizer Ltd debt-free?

Yes, Pfizer Ltd is debt-free with a debt-to-equity ratio of 0.01.

Home

Pfizer Ltd

Pfizer Ltd Financials

Pfizer Ltd Financial Statement

Pfizer Ltd Income Statement

Quarterly

Annual

*All values are in Rs. Cr

Particulars	Mar 2025	Dec 2024	Sep 2024
Revenue	809.30	580.75	631.66
Operating Expense	364.41	392	399.34
Net Profit	330.94	127.60	158.35
Net Profit Margin	40.89	21.97	25.07
Earning Per Share	72.34	27.89	34.61
EBIDTA	449.09	194.01	235.33
Effective Tax Rate	22.27	26.54	25.78

Particulars	Mar 2025
Revenue	809.30
Operating Expense	364.41
Net Profit	330.94
Net Profit Margin	40.89
Earning Per Share	72.34
EBIDTA	449.09
Effective Tax Rate	22.27

Pfizer Ltd Profit & Loss

*All values are in Rs. Cr

Standalone

Consolidated

Particulars	Mar 2025	Mar 2024	Mar 2023
Total Revenue Annual	2,281.35	2,193.17	2,424.76
Operating Expenses Annual	1,541.12	1,557.87	1,615.90
Operating Profit Annual	1,085.29	823.76	942.91
Interest Annual	8.41	15.41	13.39
Depreciation	50.83	52.32	55.19
Net Profit Annual	767.60	551.33	623.93
Tax Annual	248.49	194.74	200.08

Particulars	Mar 2025
Total Revenue Annual	2,281.35
Operating Expenses Annual	1,541.12
Operating Profit Annual	1,085.29
Interest Annual	8.41
Depreciation	50.83
Net Profit Annual	767.60
Tax Annual	248.49

Pfizer Ltd Cash Flow

*All values are in Rs. Cr

Standalone

Consolidated

Particulars	Mar 2025	Mar 2024	Mar 2023
Cash Flow at the Beginning	112	36.60	62.76
Cash Flow from Operations	659.75	256.84	355.68
Cash Flow from Investing	-71.34	53.70	-36.05
Cash Flow from Financing	-205.34	-235.14	-345.79
Cash Flow at the End	495.07	112	36.60

Particulars	Mar 2025
Cash Flow at the Beginning	112
Cash Flow from Operations	659.75
Cash Flow from Investing	-71.34
Cash Flow from Financing	-205.34
Cash Flow at the End	495.07

Pfizer Ltd Key Ratios

*All values are in Rs. Cr

Standalone

Consolidated

Particulars	Mar 2025	Mar 2024	Mar 2023
PBDIT Margin (%)	40.07	37.56	38.89
PBIT Margin (%)	37.40	34.72	34.54
PBT Margin (%)	33.00	32.47	31.98
Net PROFIT Margin (%)	33.65	25.14	25.73
Return On Networth / Equity (%)	16.40	16.21	20.55
Return On Networth /Employed (%)	21.06	21.43	25.88
Return On Assets (%)	18.84	15.59	19.30
Total Debt / Equity (X)	0.01	0.01	0.01
Asset Turnover Ratio (%)	0.56	0.62	0.75

Particulars	Mar 2025
PBDIT Margin (%)	40.07
PBIT Margin (%)	37.40
PBT Margin (%)	33.00
Net PROFIT Margin (%)	33.65
Return On Networth / Equity (%)	16.40
Return On Networth /Employed (%)	21.06
Return On Assets (%)	18.84
Total Debt / Equity (X)	0.01
Asset Turnover Ratio (%)	0.56

Pfizer Ltd Balance Sheet

*All values are in Rs. Cr

Standalone

Consolidated

Particulars	Mar 2025	Mar 2024	Mar 2023
Fixed Assets Annual	723.62	712.71	749.25
Total Current Assets Annual	3,512.85	2,737.81	2,493.34
Non Current Assets Annual	1,398.26	1,459.22	1,475.64
Total Shareholders Funds Annual	4,217.41	3,595.54	3,207.30
Total Assets Annual	4,911.11	4,228.78	4,000.73

Particulars	Mar 2025
Fixed Assets Annual	723.62
Total Current Assets Annual	3,512.85
Non Current Assets Annual	1,398.26
Total Shareholders Funds Annual	4,217.41
Total Assets Annual	4,911.11

Pfizer Ltd Earning Calls

No Data Availabe

Dividend Pages

PE Ratio

FAQS on Pfizer Ltd Financials

As of Aug 8, 2025, Pfizer Ltd has a market capitalization of 18,317.16 Cr. Value Research classifies it as a Large-Cap company.

Yes, Pfizer Ltd is with a debt-to-equity ratio of 0.01.

In FY 2024 , Pfizer Ltd recorded a total revenue of approximately 2,281.35 Cr marking a significant milestone in the company's financial performance.

Pfizer Ltd's Future outlook anticipates robust growth, with forecasted earnings and revenue rising approximately 0.1% and -0.0% annually, respectively..

Pfizer Ltd's current PE ratio is 23.86.

Pfizer Ltd's ROCE averaged 21.8% from the FY ending March 2023 to 2025, with a median of 20.6%. It peaked at 25.1% in March 2023, reflecting strong capital efficiency over the period..

Pfizer Ltd's latest EBIT is Rs. 1,024.50 Cr, surpassing the average EBIT of Rs. 874.46 Cr over the 5 years..